cagrilintide phase 2 Three new 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes cagrilintide protocol Once-weekly for weight

For anything beyond mild loss, enhanced delivery is needed

Schirra J, Sturm K, Leicht P, et al

J., Trevelin, L

In Canada, synthetic injectable peptides are generally regulated as prescription drugs under the Food and Drugs Act, and Health Canada has issued public advisories (April 2026 and earlier) cautioning that unauthorized injectable peptide products are illegal regardless of whether they are labelled 'for research use only.' Research-grade AOD-9604 supplied by Koipeptides is intended for in vitro laboratory study only and is not authorized for any human or veterinary application

When you consume a substance orally, a percentage of that substance is metabolized by the body before it can actually get into the bloodstream

Lower risk of injury Because SQ injections arent deep, they carry a lower risk of hitting a large blood vessel, nerve, or bone than deeper IM injections